Immune-related adverse events Clinical Trials
Conditions / Immune-related adverse events
Delta Trials records 10 clinical trials for Immune-related adverse events in its publicly accessible dataset. From the full dataset, 8 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 15 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
10
Total Trials
8
Recruiting
1
Completed
1
Other Active
0
Terminated since 2020
15
Study Locations
Browse by location (15 total)
- Beijing, China 2 trialsAll trials in Beijing, China
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- Basel, Switzerland 1 trialAll trials in Basel, Switzerland
- New York, United States 1 trialAll trials in New York, United States
- Jinan, China 1 trialAll trials in Jinan, China
- Jinan, China 1 trialAll trials in Jinan, China
- Leuven, Belgium 1 trialAll trials in Leuven, Belgium
- Zhengzhou, China 1 trialAll trials in Zhengzhou, China
- Freiburg Im Breisgau, Germany 1 trialAll trials in Freiburg Im Breisgau, Germany
- Boston, United States 1 trialAll trials in Boston, United States
- Fuzhou, China 1 trialAll trials in Fuzhou, China
- Guangzhou, China 1 trialAll trials in Guangzhou, China
- Shantou, China 1 trialAll trials in Shantou, China
- Sanya, China 1 trialAll trials in Sanya, China
- London, United Kingdom 1 trialAll trials in London, United Kingdom
- Pamplona, Spain 1 trialAll trials in Pamplona, Spain